Blaze Bioscience
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
530 Fairview Ave N Ste 1400, Seattle, Wa...Phone Number
(206) 535-8144Website
www.blazebioscience.comRevenue
$13.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Blaze Bioscience
Blaze Bioscience is a privately held biotechnology company focused on enhancing the lives of cancer patients, particularly children undergoing brain cancer surgery. The company utilizes its innovative Tumor Paint technology and the CANVAS imaging system to improve the detection, removal, and treatment of various cancers. Their mission is to make cancer care more sensitive, reliable, and accessible. Intended clients include healthcare providers and institutions involved in cancer treatment.Explore more
Blaze Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Blaze Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Blaze Bioscience
Earning: See what the market has to say on Blaze Bioscience recently announced quarterly report
Check if Blaze Bioscience has recently received funding, and reach out quickly before it becomes old news!
Check out if Blaze Bioscience is spiking on competitors!
Click to see if Blaze Bioscience had a recent Job posting/layoffs
Blaze Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Blaze Bioscience has new funding data
Product Launch: Get notified when Blaze Bioscience launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Blaze Bioscience
Compare insights from companies similar to Blaze Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Blaze Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Blaze Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Blaze Bioscience.
Blaze Bioscience financials insights
Gather financial insights about Blaze Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Debt
$725K
2012
Series A
$5M
2013
Series B
$9M
2015
Debt
$991K
2017
Debt
$554K
2020
Debt
$350K
2021
Debt
$421K
Blaze Bioscience Tech Stack
A closer look at the technologies used by Blaze Bioscience
Most Recent Scoops
Open Position
Open Position
New Hire
Executive Move
Joseph McKinstry has joined the organization as Senior Director, Supply Chain.
Executive Moves, New Hire
Funding
Blaze Bioscience has received an SBA PPP loan in the amount of $421,030 from Bank of America resulting in the retention of 19 jobs.
Funding
Blaze Bioscience News & Media
XOMA Announces Heather L. Franklin Joins its Board of Directors
EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Heather L. Franklin, President and Chief Executive Officer of Blaze Bioscience, Inc., has joined the Company’s Board of Directors. Ms. Franklin has significant experience in corporate development and strategy, including over 10 years of experience founding and leading Blaze and 10 years of business development experience prior to that at ZymoGenetics.Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100 (tozuleristide) for Pediatric Central Nervous System Tumors
SEATTLE--(BUSINESS WIRE)-- #BLZ100--Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100 (tozuleristide) for Pediatric Central Nervous System TumorsBlaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma
SEATTLE--(BUSINESS WIRE)--#BLZ100--Blaze Bioscience announces the publication of Phase 1 clinical trial results for Tumor Paint: BLZ-100 (tozuleristide) in adults with glioma.CORRECTING and REPLACING Blaze Bioscience Announces the Initiation of Pivotal Clinical Trial for Tumor Paint: BLZ-100 (tozuleristide) and the Canvas Imaging System
SEATTLE--(BUSINESS WIRE)--#blazebioscience--Blaze Bioscience Announces the Initiation of Pivotal Clinical Trial for Tumor Paint: BLZ-100 (tozuleristide) and the Canvas Imaging System.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Blaze Bioscience
Sign Up For FreeTo access detailed company insights
Blaze Bioscience is a privately held biotechnology company focused on enhancing the lives of cancer patients, particularly children undergoing brain cancer surgery. The company utilizes its innovative Tumor Paint technology and the CANVAS imaging system to improve the detection, removal, and treatment of various cancers. Their mission is to make ca... Read More
